Day 2 of Medica

Day 2 at MEDICA 2024 – Another Fantastic Day for Adtec Healthcare Limited!

Today marked another successful day at the MEDICA - Leading International Trade Fair. We've had the pleasure of connecting with both new and familiar faces, sharing insights, and discussing how our innovative solutions continue to advance healthcare.

Thank you to everyone who stopped by our booth to learn more about what we do. We're excited to keep building strong relationships and exploring opportunities to make a positive impact in the healthcare industry.

Looking forward to more great conversations in the days ahead! See you tomorrow at Hall 15, Booth A24-3.


Day 1 of Medica

 

Exciting Day at MEDICA 2024 in Düsseldorf!

What an incredible day connecting with industry leaders, innovators, and healthcare professionals here at the Medica exhibition! We’re thrilled with the positive response to our solutions and the inspiring conversations we’ve had with so many of you.

If you’re attending MEDICA, make sure to stop by our booth, A24-3 in Hall 15! Our team is here, ready to answer your questions and showcase how our SteriPlas Premium Cold Plasma can make a difference in healthcare. Don’t miss out on the chance to see what’s new, chat with us, and be part of this inspiring event!

Looking forward to welcoming even more of you tomorrow!


Adtec joins the MedTech World 2024 this week

We’re thrilled to announce our participation in MedTech World 2024 this week!

Join us as our CEO takes the stage for the panel discussion, "How We Do It: Investors and Entrepreneurs Together." This is a fantastic opportunity to explore innovative collaborations that drive the future of healthcare technology.

Stay tuned for insights and highlights from the event! Let’s connect and shape the future of MedTech together!

https://med-tech.world/news/improving-wound-management-adtec-healthcares-steriplas-technology-explained/


Dr Schlöglhofer presents the SteriPlas at ESAO 2024

A huge congratulations to Dr Thomas Schlöglhofer for his presentation at the European Society for Artificial Organs 2024 conference.

His presentation, “Cold Atmospheric Plasma Therapy as a Novel Treatment for Berlin Heart EXCOR Pediatric Cannula Infections” features the use of our SteriPlas Premium Cold Plasma for infection management on Berlin Heart EXCOR cannulas in Pediatric patients.

We thank Dr Schlöglhofer for his work towards this study and for recommending the SteriPlas as the only Cold Plasma device for the infection management of Berlin Heart EXCOR products.

 


SteriPlas to be presented at the DFSG conference

Adtec looks forward to supporting Ms Jemma Cruickshank, Antimicrobial Pharmacy Technician from Kettering General Hospital NHS Foundation Trust, at the Diabetic Foot Study Group (DFSG) conference in September.

Jemma has been invited to present the “Retrospective review of the use of argon cold plasma therapy in non-healing diabetic foot ulcers over a 3-year period within a DGH Diabetic Foot MDT Service” at the conference.

Her presentation will include the strong benefits of the SteriPlas on chronic and large diabetic foot ulcers prone to biofilm infections.

The abstract for this presentation can be found here: https://distribute.m-anage.com/from.storage?image=erIsXlaDuNOv64Tv4JyKY6XW3cI1HigkZNgT5cOgYv7Vzt_UHvGbDPesijzVroVO0

For more information about our SteriPlas Premium Cold Plasma medical device, send us an email info@adtecplasma.com


Day 1 of the ISHLT

An exciting start to the ISHLT 2024 show. Our SteriPlas Premium Cold Plasma medical device is being widely spoken about throughout the sessions and we welcome you to visit our booth no.12 to learn more.


Adtec joins the Innovation Platform at LSI 2024

We look forward to participating at the Innovation Platform at the @LSI USA 2024. Our CEO, Mary McGovern, will be in the Private Partnering Area between 18-22 March 2024 meeting with exclusive Medtech and Healthtech leaders to bring the rich content of the SteriPlas Premium Cold Plasma to them.

 

The SteriPlas is renowned for its proven clinical efficacy destroying chronic and complicated biofilm within infected wounds and surgical site infections. Our wide clinical bibliography of 80+ clinical trials and studies ranges from diabetic foot ulcers, LVAD infections, Sternal wound infections and so on.

Delivering a unique physical mode of action during treatment, the SteriPlas dense Cold Plasma ensures the total destruction of all bacterial species protected within biofilm which would otherwise have been resistant to antibiotics. Essentially, we are saving limbs !

We have documented the cost savings benefit due to be published this year across two separate papers focused on diabetic foot ulcers and sternal wound infections.

 

Our purpose of the LSI Innovation Platform attendance is to seek the potential of investment to help bring our medical device to new territories that have yet to benefit from what we can offer.
Cold Plasma is changing the norm of modern medicine.


Arab Health Exhibition 2024


We’re excited to be attending the Arab Health Exhibition next week to meet with our new partners across the Middle East. This year Adtec Healthcare Limited welcomes the expansion of our Cold Plasma to the MENA region, facilitated by our Distributors in their leading fields of wound care and surgical site infections.

If you would like to secure your meeting with us during the Arab Health show, please send us an email at info@adtecplasma.com


Day 4 of Medica

Day 4 of the MEDICA Trade Fair.

As the show comes to a close, we would like to thank everyone who has visited our booth. An enormous presence of Medical Distributors who have come to our booth specifically to partner with us knowing our Premium Cold Plasma technology has the leading efficacy has been very much welcomed.

You can still reach us at info@adtecplasma.com or visit our website: www.adtechealthcare.com

Safe travels for everyone going home!


Day 3 of Medica

Day 3 of the MEDICA Trade Fair. We're on booth J60.3, Hall 16 ready to welcome you to our booth and show exactly how Premium Cold Plasma is revolutionising the way patients with chronic wounds are being fully healed even if they have heavy biofilm presence.